Juha Kere Selected Research

Dyslexia (Alexia)

7/2020	Dyslexia Candidate Gene and Ciliary Gene Expression Dynamics During Human Neuronal Differentiation.
1/2020	Rare variants in dynein heavy chain genes in two individuals with situs inversus and developmental dyslexia: a case report.
10/2016	Ciliary dyslexia candidate genes DYX1C1 and DCDC2 are regulated by Regulatory Factor X (RFX) transcription factors through X-box promoter motifs.
1/2016	Genomic sequencing of a dyslexia susceptibility haplotype encompassing ROBO1.
11/2015	Mutation in CEP63 co-segregating with developmental dyslexia in a Swedish family.
7/2015	Polymorphisms in DCDC2 and S100B associate with developmental dyslexia.
1/2013	The zebrafish orthologue of the dyslexia candidate gene DYX1C1 is essential for cilia growth and function.
4/2012	The rs3743205 SNP is important for the regulation of the dyslexia candidate gene DYX1C1 by estrogen receptor β and DNA methylation.
2/2012	The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.
1/2011	SNP variations in the 7q33 region containing DGKI are associated with dyslexia in the Finnish and German populations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juha Kere Research Topics

Disease

38	Asthma (Bronchial Asthma) 10/2021 - 10/2002
16	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 03/2002
15	Inflammation (Inflammations) 06/2022 - 04/2004
13	Dyslexia (Alexia) 07/2020 - 09/2003
12	Hypersensitivity (Allergy) 04/2021 - 01/2005
11	Pre-Eclampsia (Preeclampsia) 03/2022 - 06/2009
11	Neoplasms (Cancer) 01/2021 - 11/2002
8	Obesity 01/2021 - 10/2005
6	Infections 09/2020 - 04/2010
4	Birth Weight (Birth Weights) 01/2021 - 11/2004
4	Atopic Dermatitis (Atopic Eczema) 10/2020 - 08/2005
4	Otitis Media 01/2019 - 12/2012
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015 - 03/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2010 - 09/2007
3	Congenital chloride diarrhea 01/2020 - 12/2002
3	Pregnancy Complications 01/2020 - 01/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2016 - 12/2009
3	Rheumatoid Arthritis 02/2013 - 05/2005
3	Eczema 01/2013 - 01/2009
3	Breast Neoplasms (Breast Cancer) 02/2012 - 05/2007
2	Atrophy 11/2021 - 01/2020
2	Retinal Degeneration 11/2021 - 01/2020
2	Overweight 01/2021 - 01/2016
2	Stillbirth 09/2020 - 06/2010
2	Pendred syndrome 01/2020 - 01/2006
2	Deafness (Deaf Mutism) 01/2020 - 01/2006
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2015
2	Cutaneous Lupus Erythematosus 01/2019 - 02/2010
2	Male Infertility (Male Sterility) 10/2017 - 07/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2017 - 06/2015
2	Type 2 Diabetes Mellitus (MODY) 10/2016 - 11/2004
2	Cellulitis 05/2015 - 01/2013
2	Idiopathic Pulmonary Fibrosis 03/2012 - 04/2010
2	Diarrhea 10/2008 - 12/2005
2	Hypoglycemia (Reactive Hypoglycemia) 09/2007 - 01/2003
2	Hyperinsulinism (Hyperinsulinemia) 09/2007 - 01/2003
1	Eosinophilia 04/2021
1	Rhinitis 04/2021
1	Bronchial Hyperreactivity 04/2021

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 12/2019 - 11/2002
13	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2007
13	NeuropeptidesIBA 01/2019 - 10/2006
11	Biomarkers (Surrogate Marker)IBA 04/2021 - 02/2012
11	Immunoglobulin E (IgE)IBA 01/2021 - 10/2002
10	Messenger RNA (mRNA)IBA 06/2018 - 05/2006
8	NucleotidesIBA 01/2016 - 10/2005
7	Protein Isoforms (Isoforms)IBA 06/2018 - 04/2004
7	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2010 - 04/2004
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
5	Estrogen ReceptorsIBA 04/2012 - 08/2009
5	Insulin (Novolin)FDA Link 09/2007 - 01/2003
4	AllergensIBA 04/2021 - 08/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2004
4	InterferonsIBA 09/2020 - 07/2015
4	HLA-C Antigens (HLA-C)IBA 10/2018 - 03/2002
4	Interferon Regulatory FactorsIBA 01/2014 - 03/2005
4	Estrogens (Estrogen)FDA Link 04/2012 - 06/2007
4	HLA-C*06 antigenIBA 05/2011 - 03/2002
4	OvalbuminIBA 05/2006 - 04/2004
3	AntigensIBA 03/2022 - 01/2014
3	Biological ProductsIBA 11/2020 - 06/2008
3	SaltsIBA 01/2020 - 10/2008
3	AntibodiesIBA 01/2013 - 06/2009
3	factor V LeidenIBA 06/2010 - 01/2007
3	Interferon-gamma (Interferon, gamma)IBA 12/2009 - 12/2003
2	Retinaldehyde (Retinal)IBA 11/2021 - 01/2020
2	GuanineIBA 01/2021 - 01/2018
2	HDL CholesterolIBA 01/2021 - 05/2010
2	HLA-G Antigens (HLA G)IBA 01/2021 - 09/2020
2	Vitamin D FDA LinkGeneric 01/2020 - 06/2007
2	AnionsIBA 01/2020 - 01/2006
2	ElectrolytesIBA 01/2020 - 12/2002
2	Indicators and Reagents (Reagents)IBA 12/2019 - 01/2010
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 10/2016
2	RetinoidsIBA 01/2019 - 01/2013
2	InflammasomesIBA 01/2019 - 03/2016
2	AcidsIBA 01/2019 - 01/2013
2	Heme Oxygenase-1IBA 01/2018 - 07/2014
2	UbiquitinIBA 01/2017 - 06/2011
2	EnzymesIBA 01/2017 - 10/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 09/2015
2	3' Untranslated Regions (3' UTR)IBA 01/2016 - 09/2007
2	CytokinesIBA 01/2016 - 12/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 12/2012
2	Glutens (Glutelin)IBA 06/2011 - 03/2009
2	CollagenIBA 05/2011 - 03/2003
2	SilverIBA 12/2010 - 03/2008
2	TYK2 Kinase (Tyrosine Kinase 2)IBA 02/2010 - 03/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 10/2005
2	Blood Group Antigens (Blood Groups)IBA 06/2009 - 01/2007
2	Pyruvic Acid (Pyruvate)IBA 09/2007 - 01/2003
2	Hormones (Hormone)IBA 06/2007 - 10/2005
2	ChloridesIBA 01/2006 - 12/2005
2	Codon (Codons)IBA 09/2003 - 03/2003
1	Filaggrin ProteinsIBA 06/2022
1	OpsinsIBA 11/2021
1	Interleukin-13IBA 10/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2021
1	Methacholine Chloride (Methacholine)FDA Link 04/2021

Therapy/Procedure

7	Therapeutics 10/2019 - 02/2012